Prediction of Hepatitis C Recurrence in Liver Transplant Recipients

Stopped early

Conditions studied: Complication of Transplanted Liver, Hepatitis C, Chronic

In brief

The purpose of the study is to look at cells of the immune system to see if the cells are different among people with different risk factors that have received a liver transplant. We will enroll 50 patients receiving liver transplant and their donors. Both donor and recipient must participate in the order for the recipient to participate in the study. We will take blood samples from these patients and their donors.

Key facts

Study ID

NCT00867243

Run by

Northwestern University

People needed

24

Starts

2005-10-01

Expected to finish

2011-05-01

Last updated by the study team

2013-06-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must be >18 years of age
• Chronic HCV infection (and cirrhosis) - group 1
• HCV RNA positive pre-transplant - group 1
• Liver cirrhosis not due to HCV infection - group 2

You may not qualify if…

• All patients < than 18 years of age
• Patients with hepatitis C infection
• Candidates receiving multi-organ combined transplantation
• Patients who have received a previous liver transplantation
• Patients who are unable to understand English

Where it is running

• Northwestern Memorial Hospital — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.